(Q35580538)

English

Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.

scientific article published on November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. (English)

1 reference

Europe PubMed Central

9 August 2017

0 references

author name string

D Reinhardt

1

1 reference

Europe PubMed Central

9 August 2017

H H Sigusch

2

1 reference

Europe PubMed Central

9 August 2017

J Hensse

3

1 reference

Europe PubMed Central

9 August 2017

S C Tyagi

4

1 reference

Europe PubMed Central

9 August 2017

R Körfer

5

1 reference

Europe PubMed Central

9 August 2017

H R Figulla

6

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

88

1 reference

Europe PubMed Central

9 August 2017

5

1 reference

Europe PubMed Central

9 August 2017

525-530

1 reference

Europe PubMed Central

9 August 2017

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Matrix metalloproteinase inhibitors: applications in oncology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Regulation of matrix metalloproteinases following cellular transformation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Matrix metalloproteinases and their inhibitors in connective tissue remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

27 July 2018

Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

26 September 2018

Recent advances in matrix metalloproteinase inhibitors research.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

26 September 2018

Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

26 September 2018

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767416

26 September 2018

Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A tenascin knockout with a phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/12381651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HEART.88.5.525

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35580538&oldid=1525086521"